Skip to main content
Journal cover image

Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.

Publication ,  Journal Article
Jung, H; Andonian, S; Assimos, D; Averch, T; Geavlete, P; Kohjimoto, Y; Neisius, A; Philip, J; Saita, A; Shah, H; Osther, PJ
Published in: World J Urol
September 2017

PURPOSE: The aim of this review was to provide current best evidence for evaluation, dietary, and medical management of patients with urolithiasis. METHODS: Literature addressing evaluation, dietary, and medical management of urolithiasis was searched. Papers were analyzed and rated according to level of evidence (LOE), whereupon a synthesis of the evidence was made. Grade of recommendation (GOR) was judged from individual clinical experience and knowledge of the evidence according to the Oxford Centre for Evidence-based Medicine. RESULTS: It is obvious that different stone diseases influence the life of stone-forming individuals very differently, and that evaluation and medical management should be personalized according to risk of recurrence, severity of stone disease, presence of associated medical conditions, and patient's motivation. With regard to evaluation, dietary and medical management of patients with urolithiasis evidence from the literature suggest that selective metabolic evaluation may lead to rational dietary and medical management. Statements based on LOE and GOR are provided to guide clinical practice. CONCLUSION: The provided evidence for evaluation of patients with urolithiasis aims at defining patients at high risk for recurrent/complicated stone disease. Based on this approach, evidence-based dietary and medical management regimes are suggested.

Duke Scholars

Published In

World J Urol

DOI

EISSN

1433-8726

Publication Date

September 2017

Volume

35

Issue

9

Start / End Page

1331 / 1340

Location

Germany

Related Subject Headings

  • X-Ray Diffraction
  • Urology & Nephrology
  • Urolithiasis
  • Urinalysis
  • Ultrasonography
  • Tomography, X-Ray Computed
  • Spectrum Analysis
  • Sodium Chloride Symporter Inhibitors
  • Practice Guidelines as Topic
  • Potassium Citrate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jung, H., Andonian, S., Assimos, D., Averch, T., Geavlete, P., Kohjimoto, Y., … Osther, P. J. (2017). Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol, 35(9), 1331–1340. https://doi.org/10.1007/s00345-017-2000-1
Jung, Helene, Sero Andonian, Dean Assimos, Timothy Averch, Petrisor Geavlete, Yasuo Kohjimoto, Andreas Neisius, et al. “Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.World J Urol 35, no. 9 (September 2017): 1331–40. https://doi.org/10.1007/s00345-017-2000-1.
Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, et al. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017 Sep;35(9):1331–40.
Jung, Helene, et al. “Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.World J Urol, vol. 35, no. 9, Sept. 2017, pp. 1331–40. Pubmed, doi:10.1007/s00345-017-2000-1.
Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, Neisius A, Philip J, Saita A, Shah H, Osther PJ. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017 Sep;35(9):1331–1340.
Journal cover image

Published In

World J Urol

DOI

EISSN

1433-8726

Publication Date

September 2017

Volume

35

Issue

9

Start / End Page

1331 / 1340

Location

Germany

Related Subject Headings

  • X-Ray Diffraction
  • Urology & Nephrology
  • Urolithiasis
  • Urinalysis
  • Ultrasonography
  • Tomography, X-Ray Computed
  • Spectrum Analysis
  • Sodium Chloride Symporter Inhibitors
  • Practice Guidelines as Topic
  • Potassium Citrate